Bruker Preclinical Imaging stands at the forefront of advanced imaging solutions for preclinical research, offering a cutting-edge portfolio that includes MRI, MPI, Micro-CT, Molecular Imaging (MOLECUBES, PET/SPECT/CT), and Optical Imaging (Spectral Instruments Imaging, BLI/FLI/X-Ray). These technologies drive scientific discovery and therapeutic development across oncology, neurology, cardiology, inflammation, infectious diseases, and more. Specializing in small animal imaging, Bruker provides researchers with precise insights into biological processes.
BioRelo
BioRelo (Biological Relocation Solutions, LLC) is a nationwide lab moving company specializing in the safe, compliant transport and storage of temperature sensitive materials for life science organizations. Our team manages the relocation of biological materials, hazardous chemicals, infectious substances, and cold storage equipment while maintaining strict regulatory compliance and chain of custody. Our trucks operate as mobile cold rooms, supporting temperature controlled environments from ambient conditions to ultra low and cryogenic temperatures reaching -196°C. Our team has extensive experience managing the planning, transport, and delivery of ULT freezers, laboratory refrigerators, and liquid nitrogen storage systems. In addition to relocation services, BioRelo operates a secure biorepository facility offering both short term and long term storage solutions for biological samples, research materials, and clinical specimens.
BioMetas
Based in Shanghai with a presence in Boston, Massachusetts, BioMetas leverages decades of expertise to provide robust biological assays for pharmaceutical and biotech companies. With a strong foundation in CRO and early-discovery services, our customer-first approach ensures high-quality data delivered with rapid turnaround times. Through our validated in vitro and in vivo biological assays, we support the advancement of therapies that advance your discovery programs forward. BioMetas is dedicated to supporting your project team, saving you time to focus on discovering therapeutic agents that benefit patient communities.
BioMed Linkage Tech Co., Limited
BioMed Linkage provides comprehensive, one-stop solutions for CRO and CDMO services in China. We partner with top-tier CDMOs, pharmacology CROs, and GLP-certified CROs to deliver end-to-end support for drug manufacturing, pharmacology, DMPK, and toxicology studies—covering both IND- and NDA-enabling programs. We offer particular strengths in two key areas: 1. IND and NDA-Enabling Studies We specialize in DMPK and toxicology studies across multiple species, including non-human primates (NHPs), to support regulatory submissions from IND through NDA. 2. Extensive NHP Resources in China We have strong capabilities to support a wide range of NHP studies, including: • Disease models for efficacy evaluation • PK and efficacy studies using both naïve and non-naïve NHPs • Pre-tox and formal toxicology studies for IND/NDA-enabling programs With a dedicated China-based team, we offer full project management to ensure high-quality execution and strict adherence to timelines. If you’re seeking reliable and cost-effective CRO or CDMO services in China, BioMed Linkage is well positioned to be your trusted partner.
Biolight Biotechnology Co., Ltd
We provide a series of professional, optical imaging instruments. Our technology focuses on the development of high efficiency reception and recognition technology for photon signals. The technology has many applications, ranging from life science research to, environmental quality monitoring and medical diagnostic services.
Biocytogen
Biocytogen (HKEX: 02315) is a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies. Founded on gene editing technology, Biocytogen leverages genetically engineered proprietary RenMice® (RenMab/RenLite®/RenNano®/RenTCR-mimic) platforms for fully human monoclonal/bispecific/multispecific antibody discovery, bispecific antibody-drug conjugate discovery, nanobody discovery and TCR-mimic antibody discovery, and has established a sub-brand, RenBiologics, to explore global partnerships for an off-the-shelf library of >400,000 fully human antibody sequences against approximately 1000 targets. As of June 30, 2023, 50 therapeutic antibody and multiple clinical asset co-development/out-licensing/transfer agreements and 42 target-nominated RenMice® licensing projects have been established around the globe, including several partnerships with multinational pharmaceutical companies (MNCs). Biocytogen pioneered the generation of drug target knock-in humanized models for preclinical research, and currently provides a few thousand off-the-shelf animal and cell models under the company’s sub-brand, BioMice, along with preclinical pharmacology and gene-editing services for clients worldwide. Headquartered in Beijing, Biocytogen has branches in China (Haimen Jiangsu, Shanghai), USA (Boston, San Francisco), and Germany (Heidelberg).
BIOEMTECH
BIOEMTECH’s mission and passion is accelerating preclinical research of promising drugs, towards clinical translation, through high quality services and products. BIOEMTECH offers boutique laboratories for evaluating new compounds in all stages of preclinical testing and has developed the eyes™ desktop cameras for real-time in vivo imaging of radionuclides and dyes. The eyes™ also allow for in vivo imaging of alpha emitters (212Pb & 225Ac) in oncological models and short scanning times. Both in BIOEMTECH’s services and products, fast screening applications are a core company value towards accelerating drug development.
Beijing InnoModels Biotechnologies
Founded in 2020, Beijing InnoModels Biotechnologies is a preclinical CRO specializing in oncology and immuno-oncology research. The company provides comprehensive in vivo and in vitro pharmacology services, including molecular and cellular biology, PDO, CDX, PDX, and syngeneic tumor models, humanized mouse models, PK/PD studies, flow cytometry, in vivo imaging, and non-GLP toxicology. InnoModels has supported over 600 partners across more than 2,000 projects, offering integrated platforms that bridge the gap between preclinical and clinical development. Its advanced humanized immune system and PDX model platforms enable efficient evaluation of immunotherapies and early assessment of clinical value. Backed by an experienced scientific team, InnoModels is committed to accelerating drug development through innovative and reliable preclinical solutions.
ALZET LLC.
ALZET pumps are small, implantable devices designed to deliver agents continuously to lab animals at precise rates regardless of molecular weight. Over 24,000 publications demonstrate their ability to reliably deliver compounds like chemotherapeutics, hormones, inhibitors – systemically or directly to the tumor. iPRECIO programmable pumps are available for more complex dosing.